Effect of abciximab on myocardial salvage in patients with acute myocardial infarction undergoing primary angioplasty

In acute myocardial infarction (AMI), timely reperfusion is a prerequisite to limit the extent of infarct size. Lee et al tested the hypothesis that abciximab, given at the time of primary angioplasty for AMI, may produce a greater degree of myocardial salvage.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The American journal of cardiology 2002-12, Vol.90 (11), p.1243-1246
Hauptverfasser:	Lee, Cheol Whan, Moon, Dae-Hyuk, Hong, Myeong-K.i, Lee, Jae-Hwan, Choi, S.i-Wan, Yang, Hyun Suk, Kim, Jae-Joong, Park, Seong-Wook, Park, Seung-Jung
Format:	Artikel
Sprache:	eng
Schlagworte:	Abciximab Aged Angioplasty Angioplasty, Balloon, Coronary Antibodies, Monoclonal - therapeutic use Biological and medical sciences Blood. Blood coagulation. Reticuloendothelial system Clinical outcomes Coronary Angiography Drug therapy Female Heart attacks Humans Immunoglobulin Fab Fragments - therapeutic use Male Medical sciences Middle Aged Myocardial Infarction - therapy Myocardial Reperfusion Injury - prevention & control Pharmacology. Drug treatments Platelet Aggregation Inhibitors - therapeutic use Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	In acute myocardial infarction (AMI), timely reperfusion is a prerequisite to limit the extent of infarct size. Lee et al tested the hypothesis that abciximab, given at the time of primary angioplasty for AMI, may produce a greater degree of myocardial salvage.
ISSN:	0002-9149 1879-1913
DOI:	10.1016/S0002-9149(02)02843-6